LT2523975T - Bakterinis šeimininko kamienas, apimantis mutantinį spr geną ir laukinio tipo tsp geną - Google Patents
Bakterinis šeimininko kamienas, apimantis mutantinį spr geną ir laukinio tipo tsp genąInfo
- Publication number
- LT2523975T LT2523975T LTEP11700144.6T LT11700144T LT2523975T LT 2523975 T LT2523975 T LT 2523975T LT 11700144 T LT11700144 T LT 11700144T LT 2523975 T LT2523975 T LT 2523975T
- Authority
- LT
- Lithuania
- Prior art keywords
- gene
- wild
- bacterial host
- host strain
- mutant spr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/22—Processes using, or culture media containing, cellulose or hydrolysates thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/26—Processes using, or culture media containing, hydrocarbons
- C12N1/28—Processes using, or culture media containing, hydrocarbons aliphatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1000590.8A GB201000590D0 (en) | 2010-01-14 | 2010-01-14 | Bacterial host strain |
PCT/EP2011/050415 WO2011086138A1 (en) | 2010-01-14 | 2011-01-13 | Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2523975T true LT2523975T (lt) | 2019-09-25 |
Family
ID=42028360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP11700144.6T LT2523975T (lt) | 2010-01-14 | 2011-01-13 | Bakterinis šeimininko kamienas, apimantis mutantinį spr geną ir laukinio tipo tsp geną |
Country Status (23)
Country | Link |
---|---|
US (2) | US8969037B2 (lt) |
EP (1) | EP2523975B1 (lt) |
JP (1) | JP5960607B2 (lt) |
KR (1) | KR101741865B1 (lt) |
CN (1) | CN102712694B (lt) |
AU (2) | AU2011206586B2 (lt) |
BR (1) | BR112012016807B1 (lt) |
CA (1) | CA2785931C (lt) |
CY (1) | CY1122174T1 (lt) |
DK (1) | DK2523975T3 (lt) |
ES (1) | ES2747981T3 (lt) |
GB (1) | GB201000590D0 (lt) |
HK (1) | HK1176942A1 (lt) |
HR (1) | HRP20191815T1 (lt) |
HU (1) | HUE046420T2 (lt) |
LT (1) | LT2523975T (lt) |
ME (1) | ME03561B (lt) |
PL (1) | PL2523975T3 (lt) |
PT (1) | PT2523975T (lt) |
RS (1) | RS59417B1 (lt) |
SG (1) | SG182279A1 (lt) |
SI (1) | SI2523975T1 (lt) |
WO (1) | WO2011086138A1 (lt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101758942B1 (ko) | 2009-09-24 | 2017-07-17 | 유씨비 파마, 에스.에이. | 박테리아 숙주 균주 |
GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201000591D0 (en) * | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201001791D0 (en) | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
EP3339325A1 (en) * | 2011-07-13 | 2018-06-27 | UCB Biopharma SPRL | Bacterial host strain expressing recombinant dsbc |
EP2737050A4 (en) * | 2011-07-25 | 2015-01-21 | Pfizer | RECOMBINANT APOA-1M FROM A BACTERIA PRODUCED BY GENETIC ENGINEERING |
GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
EP4253548A3 (en) | 2014-12-22 | 2024-01-03 | UCB Biopharma SRL | Protein manufacture |
BR112018015259A2 (pt) | 2016-01-27 | 2018-12-18 | Medimmune Llc | métodos para preparação de anticorpos com um padrão de glicosilação definido |
CN110055202B (zh) * | 2019-03-15 | 2023-08-22 | 百奥泰生物制药股份有限公司 | 用于高表达外源蛋白的大肠杆菌及其构建方法与应用 |
CN114829578A (zh) * | 2019-08-05 | 2022-07-29 | 瓦克化学股份公司 | 用于在发酵方法中释放重组蛋白的细菌菌株 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264365A (en) | 1990-11-09 | 1993-11-23 | Board Of Regents, The University Of Texas System | Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides |
US5508192A (en) | 1990-11-09 | 1996-04-16 | Board Of Regents, The University Of Texas System | Bacterial host strains for producing proteolytically sensitive polypeptides |
GB9215540D0 (en) | 1992-07-22 | 1992-09-02 | Celltech Ltd | Protein expression system |
US5304472A (en) | 1992-11-20 | 1994-04-19 | Genentech, Inc. | Method of controlling polypeptide production in bacterial cells |
US5639635A (en) | 1994-11-03 | 1997-06-17 | Genentech, Inc. | Process for bacterial production of polypeptides |
WO1997038123A1 (en) | 1996-04-05 | 1997-10-16 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
US6083715A (en) | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
JP2000083670A (ja) | 1998-09-09 | 2000-03-28 | Hsp Kenkyusho:Kk | DsbA/DsbB/DsbC/DsbD発現プラスミド |
JP2003503074A (ja) | 1999-06-29 | 2003-01-28 | シガ・テクノロジーズ,インコーポレイテッド | Degpプロテアーゼインヒビター類の分析方法 |
GB0006398D0 (en) | 2000-03-16 | 2000-05-03 | Novartis Ag | Organic compounds |
GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
AU8867501A (en) | 2000-09-01 | 2002-03-13 | Biogen Inc | Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
EP1314037A2 (en) | 2000-09-01 | 2003-05-28 | Biogen, Inc. | Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
US7041479B2 (en) | 2000-09-06 | 2006-05-09 | The Board Of Trustess Of The Leland Stanford Junior University | Enhanced in vitro synthesis of active proteins containing disulfide bonds |
JP4309656B2 (ja) * | 2000-12-14 | 2009-08-05 | ジェネンテック・インコーポレーテッド | 原核生物で生成させた抗体とその用途 |
NZ526134A (en) * | 2000-12-14 | 2005-07-29 | Genentech Inc | E. coli strain deficient in degP and prc and having a mutant spr gene and a method for making a polypeptide |
TWI334439B (en) | 2001-08-01 | 2010-12-11 | Centocor Inc | Anti-tnf antibodies, compositions, methods and uses |
WO2003018771A2 (en) | 2001-08-27 | 2003-03-06 | Genentech, Inc. | A system for antibody expression and assembly |
GB0124317D0 (en) | 2001-10-10 | 2001-11-28 | Celltech R&D Ltd | Biological products |
EA007905B1 (ru) | 2001-11-16 | 2007-02-27 | Байоджен Айдек Инк. | Полицистронная экспрессия антител |
GB0129105D0 (en) | 2001-12-05 | 2002-01-23 | Celltech R&D Ltd | Expression control using variable intergenic sequences |
ATE328906T1 (de) | 2002-06-28 | 2006-06-15 | Domantis Ltd | Dual-specifische liganden mit erhöhter halbwertszeit |
GB0224082D0 (en) | 2002-10-16 | 2002-11-27 | Celltech R&D Ltd | Biological products |
AU2003287345A1 (en) | 2002-10-31 | 2004-06-07 | Genentech, Inc. | Methods and compositions for increasing antibody production |
ATE528648T1 (de) | 2002-12-03 | 2011-10-15 | Ucb Pharma Sa | Verfahren zum nachweis antikörper-herstellender zellen |
GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
KR20120090094A (ko) | 2003-06-13 | 2012-08-16 | 바이오겐 아이덱 엠에이 인코포레이티드 | 아글리코실 항-cd154(cd40 리간드) 항체 및 이의 용도 |
AU2004220325B2 (en) | 2003-06-30 | 2011-05-12 | Domantis Limited | Polypeptides |
GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
WO2005011376A2 (en) | 2003-07-26 | 2005-02-10 | Biogen Idec Ma Inc | Altered antibodies having improved antigen-binding affinity |
EP1791563A4 (en) | 2004-07-26 | 2009-07-08 | Biogen Idec Inc | ANTI-CD154 ANTIBODIES |
WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
GB0425534D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
GB0520169D0 (en) | 2005-10-04 | 2005-11-09 | Celltech R&D Ltd | Biological products |
TWI417299B (zh) | 2007-03-22 | 2013-12-01 | Biogen Idec Inc | 包括抗體、抗體衍生物及抗體片段之專一性地結合至cd154之結合蛋白及其用途 |
US7662587B1 (en) * | 2009-03-05 | 2010-02-16 | E. I. Du Pont De Nemours And Company | Gene knockout mutations that increase peptide production |
KR101758942B1 (ko) | 2009-09-24 | 2017-07-17 | 유씨비 파마, 에스.에이. | 박테리아 숙주 균주 |
US8470552B2 (en) | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
US8361744B2 (en) | 2009-11-05 | 2013-01-29 | Genentech, Inc. | Methods and composition for secretion of heterologous polypeptides |
GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
GB201000588D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
GB201001791D0 (en) | 2010-02-03 | 2010-03-24 | Ucb Pharma Sa | Process for obtaining antibodies |
GB201012599D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
EP3339325A1 (en) | 2011-07-13 | 2018-06-27 | UCB Biopharma SPRL | Bacterial host strain expressing recombinant dsbc |
EP2546267A1 (en) | 2011-07-13 | 2013-01-16 | UCB Pharma S.A. | Bacterial host strain expressing recombinant DsbC |
GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
-
2010
- 2010-01-14 GB GBGB1000590.8A patent/GB201000590D0/en not_active Ceased
-
2011
- 2011-01-13 BR BR112012016807A patent/BR112012016807B1/pt not_active IP Right Cessation
- 2011-01-13 KR KR1020127021019A patent/KR101741865B1/ko active IP Right Grant
- 2011-01-13 CA CA2785931A patent/CA2785931C/en active Active
- 2011-01-13 LT LTEP11700144.6T patent/LT2523975T/lt unknown
- 2011-01-13 RS RSP20191294 patent/RS59417B1/sr unknown
- 2011-01-13 PT PT117001446T patent/PT2523975T/pt unknown
- 2011-01-13 SG SG2012047668A patent/SG182279A1/en unknown
- 2011-01-13 CN CN201180005972.4A patent/CN102712694B/zh active Active
- 2011-01-13 SI SI201131782T patent/SI2523975T1/sl unknown
- 2011-01-13 PL PL11700144T patent/PL2523975T3/pl unknown
- 2011-01-13 ME MEP-2019-281A patent/ME03561B/me unknown
- 2011-01-13 US US13/522,080 patent/US8969037B2/en active Active
- 2011-01-13 HU HUE11700144A patent/HUE046420T2/hu unknown
- 2011-01-13 WO PCT/EP2011/050415 patent/WO2011086138A1/en active Application Filing
- 2011-01-13 AU AU2011206586A patent/AU2011206586B2/en not_active Ceased
- 2011-01-13 DK DK11700144.6T patent/DK2523975T3/da active
- 2011-01-13 EP EP11700144.6A patent/EP2523975B1/en active Active
- 2011-01-13 ES ES11700144T patent/ES2747981T3/es active Active
- 2011-01-13 JP JP2012548440A patent/JP5960607B2/ja active Active
-
2013
- 2013-03-25 HK HK13103680.4A patent/HK1176942A1/zh not_active IP Right Cessation
-
2015
- 2015-02-27 US US14/633,257 patent/US9493558B2/en active Active
-
2017
- 2017-01-27 AU AU2017200545A patent/AU2017200545B2/en not_active Ceased
-
2019
- 2019-10-04 HR HRP20191815TT patent/HRP20191815T1/hr unknown
- 2019-10-11 CY CY20191101071T patent/CY1122174T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1176942A1 (zh) | 包含突變 基因以及野生型 基因的細菌宿主菌株 | |
HK1177760A1 (zh) | 包含突變體 基因且具有降低的 活性的細菌宿主菌株 | |
HK1176943A1 (en) | Bacterial host strain expressing recombinant dsbc and having reduced tsp activity dsbc tsp | |
HK1194393A1 (zh) | 表達重組 的細菌宿主菌株 | |
HK1172650A1 (zh) | 細菌宿主菌株 | |
EP2576587A4 (en) | MUTANT NGAL PROTEINS AND USES THEREOF | |
HK1201041A1 (en) | Bacterial strains expressing methylase genes and uses thereof | |
GB2470904B (en) | Angling data gathering and processing | |
EP2664671A4 (en) | New Glycosyltransferase and its use | |
WO2011040954A9 (en) | Tp53 gene expression and uses thereof | |
EP2616813A4 (en) | HOST-SUPPORTED GENETIC BIOSENSORS | |
GB201000605D0 (en) | Bacterial host strain | |
GB201000589D0 (en) | Bacterial host strain | |
GB0916817D0 (en) | Bacterial host strain | |
GB0916822D0 (en) | Bacterial host strain | |
GB0916821D0 (en) | Bacterial host strain | |
AU2009903016A0 (en) | Novel Gene and Product | |
AU2009900554A0 (en) | Culture product and methods (A) | |
AU2011905429A0 (en) | A user interface system and computer program | |
AU2010905444A0 (en) | Sensor Data Processing | |
AU2010904617A0 (en) | Sensor data processing | |
AU2010903813A0 (en) | Sensor data processing | |
AU2009900095A0 (en) | Infrared interactive whiteboard stylus |